The Market For mRNA Vaccines & Therapeutics
Discover the exciting future of mRNA vaccines market in the "The Market For mRNA Vaccines & Therapeutics" video. Pfizer and Moderna's announcement of an mRNA-based universal flu vaccine sets the stage for groundbreaking advancements in mRNA technology. To explore what lies ahead, watch this segment from the Bioprocess Online Live event titled "mRNA Manufacturing: Bright Future, Big Challenges."
Join the discussion with industry experts, including Roberta Duncan (VP of the mRNA program at Seqirus), Jason Dickens, Ph.D. (Associate Director of Upstream and Downstream Process Development at Duke Human Vaccine Institute), and Jin Zhou (Executive Director of Process Development for mRNA and Protein Biologics at Ultragenyx). Gain insights into forecasts for mRNA vaccines and therapeutics market, and learn about the companies' strategic plans to meet the rising demands. For detailed information and an insider's perspective, watch the video and stay informed about the exciting prospects of mRNA technology.
Get unlimited access to:
Enter your credentials below to log in. Not yet a member of Bioprocess Online? Subscribe today.